WORLD Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma Thursday, May 21, 2026 · globenewswire Advertisement Read Original Article → Related Dispatches [US] · May 30 'He could have most of the field in trouble by the home turn ' - can David Jennings follow up his 8-1 winner the last time he was in the chair? [US] · May 30 Constitution River faces date with destiny as Aidan O'Brien unleashes three-pronged attack in French Derby [US] · May 30 'It's hard to know where the ceiling of his ability lies' - Tom Segal with two double-priced fancies in French Derby